GLP-1
- Health
Semaglutide patent expires in India: Price drop expected for weight-loss drugs
The patent protection period in India for semaglutide, the active ingredient in Ozempic developed by the Denmark-based healthcare company Novo…
Read More »
The patent protection period in India for semaglutide, the active ingredient in Ozempic developed by the Denmark-based healthcare company Novo…
Read More »